Advisors
Advisors of the Graduate Program in Biotechnology (PPIB)
Universidade de São Paulo/Instituto Butantan/Instituto de Pesquisa Tecnológica
(Update on October/10/2021)
(Lattes is a curriculum vitae of the Brazilian government)
FULL Advisors (which can accept new students without re-accreditation)
(For the period of accreditation, please access USP Janus System with “Código da Área:” 87131)
Name – Institution | Research focus | Email (@) | Lattes (#) |
---|---|---|---|
Aldo Tonso Escola Politécnica/USP |
Bioprocess Engineering, with emphasis on: bioproducts production with animal cells, production of asparaginase, andmonitoring and control of cultures in bioreactors (sites.usp.br/genbio) | @ | # |
Ana Clara Guerrini Schenberg Instituto de Ciências Biomédicas/USP |
Biotechnological approaches for Sustainable Development | @ | # |
Ana Lucia Tabet Oller do Nascimento Instituto Butantan |
Functional Genomics of Leptospira interrogans: pathogenesis, vaccine and diagnostic | @ | # |
Ana Maria Moro Instituto Butantan |
Development of monoclonal antibodies, antibodies’ humanization, neutralizing human antibodies, antibodies’ engineering, cell line development, cell cultivation processes | @ | # |
Ana Marisa Chudzinski Tavassi Instituto Butantan |
# | ||
Ana Olívia de Souza Instituto Butantan |
Use of microorganisms in obtainment of bioactive molecules and biosynthesis of metallic nanoparticles for the development of products and/or nanomaterials for pharmaceutical or biotechnological use | @ | # |
Andrea Balan Fernandes Instituto de Ciências Biomédicas/USP |
Our group’s main objective is the study of membrane and associated proteins involved in the import and export of different molecules in all organisms | @ | # |
Anita Mitico Tanaka Azevedo Instituto Butantan |
Biochemistry of snake plasmas and venoms and isolated proteins, focusing in factor that influence venom variability, such as seasonal variation, captivity, age and sex, as well as on antivenoms and phospholipases A2 inhibitors | @ | # |
Carlos Frederico Martins Menck Instituto de Ciências Biomédicas/USP |
This work aims to understand the molecular mechanisms that ensure genomic stability in cells, and the consequences of unrepaired DNA damage, such as carcinogenesis and aging | @ | # |
Douglas Galante Centro Nacional de Pesquisa em Energia e Materiais/Campinas |
# | ||
Eliana Nakano Instituto Butantan |
– Development of anthelminthic drugs from natural sources using new approaches (metabolomic analysis) – Environmental studies: toxicity and mutagenicity analysis (molluscs as bioindicators) |
@ | # |
Eliane Namie Miyaji Instituto Butantan |
Evaluation of protein antigens in the development of vaccines against Streptococcus pneumoniae, focusing on the study of cross-reactivity with different isolates and use of nanoparticles | @ | # |
Eny Iochevet Segal Floh Instituto de Biociências/USP |
# | ||
Felipe Santiago Chambergo Alcalde Escola de Artes, Ciências e Humanidades/USP |
Expert in molecular biology, metagenomics and biotechnological processes | @ | # |
Fernanda Calheta Vieira Portaro Instituto Butantan |
Purification and characterization of biomolecules present in venoms and secretions from animals for pharmaceutical or biotechnological use. Enzymatic analyses of substrates and inhibitors | @ | # |
Gabriel Padilla Maldonado Instituto de Ciências Biomédicas/USP |
# | ||
Igor Cesarino Instituto de Biociências/USP |
Unraveling molecular mechanisms underlying different aspects of lignin metabolism. Lignin bioengineering is envisaged to generate optimized crops with enhanced biomass extractability for biorefineries | @ | # |
João Tadeu Ribeiro Paes Universidade Estadual Paulista/Assis |
# | ||
José Antonio Visintin Faculdade de Medicina Veterinária e Zootecnia/USP |
# | ||
José Gregório Cabrera Gomez Instituto de Ciências Biomédicas/USP |
Metabolic Engineering applied to bioprocesses to replace petrochemical products (Biorefineries). Bacterial metabolism (Bioproducts synthesis and consumption of low-cost raw materials) | @ | # |
José Ribamar dos Santos Ferreira Júnior Escola de Artes, Ciências e Humanidades/USP |
We express human genes in yeast (humanized yeast) to screen for natural products that inhibit proteins involved in diseases related to aging (heart disease, neurodegenerative, and neoplasic) | @ | # |
Kelly Ishida Instituto de Ciências Biomédicas/USP |
To develop new antifungals by the following strategies: natural products,synthetic molecules, drug repurposing, incorporation of antifungal agents in carrier systems, using in vitro andin vivo models | @ | # |
Luciana Cezar de Cerqueira Leite Instituto Butantan |
# | ||
Lucio Holanda Gondim de Freitas Júnior Instituto de Ciências Biomédicas/USP |
# | ||
Luis Carlos de Souza Ferreira Instituto de Ciências Biomédicas/USP |
Vaccine Development Laboratory (LDV): vaccines based on purified recombinant proteins, DNA and mRNA vaccines (genetic vaccines) as well as vectorized vaccines | @ | # |
Luiziana Ferreira da Silva Instituto de Ciências Biomédicas/USP |
# | ||
Lygia da Veiga Pereira Carramaschi Instituto de Biociências/USP |
# | ||
Marcelo Palma Sircili Instituto Butantan |
Bacteria and host- bacteria interactions mediated by chemical signaling, and quorum sensing. Bacterial pathogenicity, gene regulation, and biofilm formation mediated by signaling molecules | @ | # |
Marcos Silveira Buckeridge Instituto de Biociências/USP |
# | ||
Margareth de Lara Capurro Guimaraes Instituto de Ciências Biomédicas/USP |
# | ||
Mari Cleide Sogayar Faculdade de Medicina/USP |
# | ||
Marie Anne van Sluys Instituto de Biociências/USP |
# | ||
Natália Neto Pereira Cerize Instituto de Pesquisas Tecnológicas/IPT |
# | ||
Oswaldo Keith Okamoto Instituto de Biociências/USP |
Research, development and innovation, focusing on stem cell biology and cancer, translationalgenomics and development of advanced therapies applied to human health | @ | # |
Pedro Ismael da Silva Junior Instituto Butantan |
Study of bioactive molecules of toxins of invertebrates and hemolymph (purification, characterization and synthesis), acting on the following topics: antimicrobial, antiviral and antitumor | @ | # |
Renato Mancini Astray Instituto Butantan |
Development of viral vaccines using isolates, attenuated viruses or recombinant expression. Studies on technologies and processes for the production and purification of viruses for pharmaceutical use | @ | # |
Rosane Aparecida Moniz Piccoli Instituto de Pesquisas Tecnológicas/IPT |
Bioprocess Optimization in bioreactors: in the production of recombinant proteins, bio products and vaccines; in the modeling, simulation and mathematical bioprocess optimization; in economic feasibility studies for biotechnological processes. | @ | # |
Soraia Attie Calil Jorge Instituto Butantan |
# | ||
Viviane Maimoni Gonçalves Instituto Butantan |
Bioprocess development for production of new vaccines, including microbial cell culture to reach high cell density in bioreactor and scalable processes for purification of the antigens | @ | # |
PONTUAL Advisers (who need to require accreditation for each new student)
Name – Institution | Research focus | Email (@) | Lattes (#) |
---|---|---|---|
Adriana Rios Lopes Rocha Instituto Butantan |
Molecular physiology in Arachnida: digestion, envenoming and enzymatic catalysis. Characterization of proteins and enzymes involved in digestion (spiders, scorpions, ticks and mites) | @ | # |
Alexandre Paulo Yague Lopes Instituto Butantan |
Main projects are “Studies on bacterial toxin-antitoxin systems of Leptospira interrogans“, in addition to the “Expression of recombinant proteins of biotechnological importance in E. coli“ | @ | # |
Alfredo Eduardo Maiorano Instituto de Pesquisas Tecnológicas – IPT |
Our research work is focused on the development of bioprocesses for obtaining bioproducts of societal value | @ | # |
Antônio José Piantino Ferreira Faculdade de Medicina Veterinária e Zootecnia – USP |
# | ||
Beatriz Nogueira Messias de Miranda Instituto de Pesquisas Tecnológicas – IPT |
# | ||
Beny Spira Instituto de Ciências Biomédicas – USP |
# | ||
Carlos Roberto Jorge Soares Instituto de Pesquisas Energéticas e Nucleares |
# | ||
Denise Vilarinho Tambourgi Instituto Butantan |
To isolate and characterize components of animal venoms and their respective modes of action, to establish the basis for the development of more efficient therapeutic strategies for the envenomations | @ | # |
Elen Aquino Perpetuo Universidade Federal de São Paulo – Santos |
Experience in the areas of Applied Microbiology and Bioprocesses, working mainly in the development of biotechnological processes for bioremediation, obtaining bioproducts and producing biofuels | @ | # |
Elizabeth Natal de Gaspari Instituto Adolfo Lutz |
New antigenic preparations for different pathogens of public health interest. Evaluation of new adjuvants focusing on humoral, cellular, mucosal and monoclonal with the aim of technological transfer | @ | # |
Fabio Luiz Teixeira Goncalves Instituto de Astronomia, Geofísica e Ciências Atmosféricas – USP |
# | ||
Fabio Rodrigues Instituto de Química – USP |
# | ||
Giovana Cappio Barazzone Instituto Butantan |
Development of conjugate vaccines. Chemical modification of molecules with biotechnological applications.Purification of recombinant proteins | @ | # |
Gustavo Cabral de Miranda Instituto de Ciências Biomédicas – USP |
# | ||
Júlia Pinheiro Chagas da Cunha Instituto Butantan |
# | ||
Karen de Morais Zani Instituto Butantan |
Compositional and functional characterization of snake venoms; Isolation and characterization of biomolecules; Natural inhibitors of snake plasma | @ | # |
Katiucia Batista da Silva Paiva Instituto de Ciências Biomédicas – USP |
Bone bioengineering, biomaterials and biological mineralization; Odontogenic tumors and oral cancer | @ | # |
Leo Kei Iwai Instituto Butantan |
Focused on the study of snakes and scorpion potential anti-tumorigenic effects and the experimental mass spectrometry-based proteomics study of snake envenomation | @ | # |
Lilian Rumi Tsuruta Instituto Butantan |
Monoclonal antibodies using phage display technology, expertise in the construction of naïve or immune library of antibody genes, antibody humanization and expression of recombinant protein in bacteria | @ | # |
Maria Filomena de Andrade Rodrigues Instituto de Pesquisas Tecnológicas – IPT |
# | ||
Maria José de Jesus Silva Instituto Butantan |
Biodiversity: genetics and conservation | @ | # |
Maria Leonor Sarno de Oliveira Instituto Butantan |
Development of vaccines against Streptococcus pneumoniae (pneumococcus). Study of combinations of protein antigens with adjuvants, antigen presentation systems and inoculation routes | @ | # |
Maria Lucia Zaidan Dagli Faculdade de Medicina Veterinária e Zootecnia/USP |
# | ||
Monamaris Marques Borges Instituto Butantan |
Immunology and microbiology associated with host-pathogen interaction. Investigation of compounds. Regulation of macrophage activity in bacterial infections. Immunology in Infections | @ | # |
Paolo Marinho de Andrade Zanotto Instituto de Ciências Biomédicas – USP |
# | ||
Patricia Léo Instituto de Pesquisas Tecnológicas – IPT |
Biotechnological processes with mammalian cell culture. Evaluation of the antitumor, antiviral and antimicrobial safety and efficacy of nanostructured material and different bioactives | @ | # |
Patrícia Severino Instituto Israelita de Ensino e Pesquisa Albert Einstein |
Genomics, gene expression regulation and molecular epidemiology, aiming at the integration of clinical and molecular markers and genome diversity (cancer progression and infections) | @ | # |
Renata Castiglioni Pascon Universidade Federal de São Paulo – Diadema |
# | ||
Rita de Cassia Cafe Ferreira Instituto de Ciências Biomédicas – USP |
# | ||
Viviane Abreu Nunes Cerqueira Dantas Escola de Artes, Ciências e Humanidades – USP |
Expertise in stem cell biology, skin physiology and tissue bioengineering, in addition to studying the molecular mechanism of chronic non-communicable diseases such as gestational diabetes | @ | # |
NEW Advisors
If you are interested in being an advisor for the program, please see “Normas”available in the Program / Normas menu, in particular item X (Advisors and co-advisors), of the Regulation of the new Biotechnology Program.